These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 23743281
1. Synthesis and in vitro evaluation of [18F]BMS-754807: a potential PET ligand for IGF-1R. Majo VJ, Arango V, Simpson NR, Prabhakaran J, Kassir SA, Underwood MD, Bakalian M, Canoll P, John Mann J, Dileep Kumar JS. Bioorg Med Chem Lett; 2013 Jul 15; 23(14):4191-4. PubMed ID: 23743281 [Abstract] [Full Text] [Related]
2. Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2. Prabhakaran J, Arango V, Majo VJ, Simpson NR, Kassir SA, Underwood MD, Polavarapu H, Bruce JN, Canoll P, Mann JJ, Kumar JS. Bioorg Med Chem Lett; 2012 Aug 01; 22(15):5104-7. PubMed ID: 22749281 [Abstract] [Full Text] [Related]
5. Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B). Nag S, Lehmann L, Kettschau G, Heinrich T, Thiele A, Varrone A, Gulyas B, Halldin C. Bioorg Med Chem; 2012 May 01; 20(9):3065-71. PubMed ID: 22436387 [Abstract] [Full Text] [Related]
6. Synthesis of N-(3-(4-[11C]methylpiperazin-1-yl)-1-(5-methylpyridin-2-yl)-1H-pyrazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide as a new potential PET agent for imaging of IRAK4 enzyme in neuroinflammation. Wang X, Xu W, Miao C, Dong F, Li W, Wang M, Gao M, Zheng QH, Xu Z. Appl Radiat Isot; 2018 Feb 01; 132():6-12. PubMed ID: 29127936 [Abstract] [Full Text] [Related]
8. Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates. Majo VJ, Milak MS, Prabhakaran J, Mali P, Savenkova L, Simpson NR, Mann JJ, Parsey RV, Kumar JS. Bioorg Med Chem; 2013 Sep 01; 21(17):5598-604. PubMed ID: 23816046 [Abstract] [Full Text] [Related]
9. Radiosynthesis of [18F]ATPFU: a potential PET ligand for mTOR. Majo VJ, Simpson NR, Prabhakaran J, Mann JJ, Kumar JS. J Labelled Comp Radiopharm; 2014 Nov 01; 57(13):705-9. PubMed ID: 25359578 [Abstract] [Full Text] [Related]
13. Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression. Prabhakaran J, Underwood MD, Parsey RV, Arango V, Majo VJ, Simpson NR, Van Heertum R, Mann JJ, Kumar JS. Bioorg Med Chem; 2007 Feb 15; 15(4):1802-7. PubMed ID: 17166726 [Abstract] [Full Text] [Related]
17. Radiosynthesis of (S)-[18F]T1: The first PET radioligand for molecular imaging of α3β4 nicotinic acetylcholine receptors. Sarasamkan J, Fischer S, Deuther-Conrad W, Ludwig FA, Scheunemann M, Arunrungvichian K, Vajragupta O, Brust P. Appl Radiat Isot; 2017 Jun 15; 124():106-113. PubMed ID: 28365525 [Abstract] [Full Text] [Related]
18. Synthesis of [¹¹C]PBR06 and [¹⁸F]PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO). Wang M, Gao M, Miller KD, Zheng QH. Steroids; 2011 Nov 15; 76(12):1331-40. PubMed ID: 21756927 [Abstract] [Full Text] [Related]